| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthetic peptide corresponding to a sequence at the C-terminus of human HOXB6 was used as the immunogen for the HOXB6 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
HOXB6 Antibody / Homeobox protein Hox-B6 is a anti-HOXB6 Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), Flow cytometry (FACS) with listed reactivity in Human, Mouse, Rat.
Key elements and design rationale
- Target: HOXB6
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, FACS
Biological background
During development, HOXB6 expression is restricted to specific regions of the embryo corresponding to the thoracic and lumbar domains. It contributes to the specification of vertebrae and rib patterning and influences limb and neural development. In adult tissues, HOXB6 expression is largely downregulated but can be reactivated in certain cell lineages, particularly within the hematopoietic system. Overexpression of HOXB6 has been observed in leukemias, where it drives proliferation and disrupts differentiation by altering transcriptional programs that control cell fate.
The HOXB6 antibody is a valuable reagent for developmental biology and cancer research. Western blot analysis detects a 25 kilodalton band corresponding to HOXB6, and immunohistochemical staining shows nuclear localization consistent with its role as a transcription factor. The antibody supports studies examining HOX gene regulation, retinoic acid signaling, and transcriptional networks controlling tissue differentiation. In experimental systems, HOXB6 expression is used as a marker of posterior HOX cluster activation, which defines segmental identity and developmental timing.
Functionally, HOXB6 binds to enhancer regions of genes that regulate cell cycle progression and differentiation, including MYC and CDKN1A. Dysregulation of HOXB6 is implicated in oncogenesis, particularly in acute myeloid leukemia, where it cooperates with MEIS1 to promote leukemic transformation. In solid tumors, aberrant HOXB6 expression correlates with invasive potential and epithelial-mesenchymal transition. The HOXB6 antibody facilitates detection of these expression changes, enabling characterization of HOX-mediated gene regulation in both normal and malignant cells.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
